- Regulatory information： REACH注册物质：状态：活跃 更新：2017-11-07 https://echa.europa.eu/registration-dossier/-/registered-dossier/21084
- interaction： 接受/同时/解热治疗的患者可能有严重低温的风险...与中枢神经系统抑制剂的作用相加，或可能增强其作用...阿托品、降压药、麻醉剂、巴比妥类药物...其他镇静剂、麻醉剂、安定药...酒精。/酒石酸盐/
- Hazard categories and classifications： 水环境慢性2（100%）
- Antidote and first aid： 严重低血压/过量引起/可通过...静脉注射去甲肾上腺素...或苯肾上腺素输注缓解...麻黄碱、安非他明或咖啡因与苯甲酸钠可使用/作为兴奋剂/。低温...难以控制...交换输注可能有用...血液透析...价值不大。/酒石酸盐/
- Drug Induced Liver Injury： 参考文献：DOI:10.1016/j.drudis.2019.09.022
Warm reminder：
Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！
Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.
Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！
alimemazine, H 1 receptorantagonist 5mg
alimemazine, H 1 receptorantagonist 5mg; supplied for laboratory research, analysis, inspection, and scientific procurement use; specifications: 5mg.
5mg
